Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity

Diabetes

Volumn 51, Issue 4, 2002, Pages 1093-1101

  Maquoi, Erik ^a   Munaut, Carine ^b   Colige, Alain ^b   Collen, Désiré ^a   Roger Lijnen, H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE B; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 24; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 3; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; LIPID DIET; LIPOGENESIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TISSUE LEVEL; ZYMOGRAPHY;

EID: 0036227213     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.1093     Document Type: Article

References (36)

1. Adipose tissue as an endocrine organ
2. Obesity may be due to a malfunctioning of brown fat
3. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue
4. Obesity and insulin resistance
5. Obesity as a medical problem
6. A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives
7. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
8. The adipocyte and hemostatic balance in obesity: Studies of PAI-1
9. Plasminogen activator inhibitor 1, transforming growth factor-beta 1, and BMI are closely associated in human adipose tissue during morbid obesity
10. Changing views of the role of matrix metalloproteinases in metastasis
11. Emerging roles for proteinases in cancer
12. Development of matrix metalloproteinase inhibitors in cancer therapy
13. Matrix metalloproteinases
14. Tissue inhibitors of metalloproteinases structure, regulation and biological functions
15. Guidelines for the use of animals in biomedical research
16. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue
17. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis
18. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor
19. Purification of progelatinases A and B by continuous-elution electrophoresis
20. Angiotensin II receptors in human preadipocytes: Role in cell cycle regulation
21. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: Induction by tumor necrosis factor-alpha and lipopolysaccharide
22. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis
23. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues
24. Regional differences in protein production by human adipose tissue
25. Potential role of leptin in angiogenesis: Leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro
26. Matrix metalloproteinases: Multifunctional contributors to tumor progression
27. Fibronectins and basal lamina molecules expression in human subcutaneous white adipose tissue
28. Adipose tissue expression of gelatinases in mouse models of obesity
29. Adipocyte produces matrix metalloproteinases 2 and 9: Involvement in adipose differentiation
30. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
31. Control of adipocyte differentiation
32. Transcriptional regulation of gene expression during adipocyte differentiation
33. Distinct transcriptional profiles of adipogenesis in vivo and in vitro
34. The expression of adipogenic genes is decreased in obesity and diabetes mellitus
35. Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor
36. Stromelysin-1 regulates adipogenesis during mammary gland involution